[HTML][HTML] Clinical features and prognostic factors in Covid-19: a prospective cohort study
…, P Bonta, L Bos, M Botta, J de Brabander, G de Bree… - …, 2021 - thelancet.com
Background Mortality rates are high among hospitalized patients with COVID-19, especially
in those intubated on the ICU. Insight in pathways associated with unfavourable outcome …
in those intubated on the ICU. Insight in pathways associated with unfavourable outcome …
Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience
DM Ouweneel, J de Brabander… - … Heart Journal: Acute …, 2019 - academic.oup.com
Aims Mortality in cardiogenic shock patients remains high. Short-term mechanical circulatory
support with Impella can be used to support the circulation in these patients, but data from …
support with Impella can be used to support the circulation in these patients, but data from …
Serologic surveillance and phylogenetic analysis of SARS-CoV-2 infection among hospital health care workers
…, AR Schuurman, J de Brabander… - JAMA network …, 2021 - jamanetwork.com
Importance It is unclear when, where, and by whom health care workers (HCWs) working in
hospitals are infected with SARS-CoV-2. Objective To determine how often and in what …
hospitals are infected with SARS-CoV-2. Objective To determine how often and in what …
[HTML][HTML] Autoantibodies neutralizing type I IFNs in the bronchoalveolar lavage of at least 10% of patients during life-threatening COVID-19 pneumonia
…, LS Boers, C Conil, L Bizien, J De Brabander… - Journal of Clinical …, 2023 - Springer
Autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) are found in the blood of at
least 15% of unvaccinated patients with life-threatening COVID-19 pneumonia. We report …
least 15% of unvaccinated patients with life-threatening COVID-19 pneumonia. We report …
[HTML][HTML] Indoleamine 2, 3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19
…, J de Brabander, G Bree, S de Bruin… - The Journal of …, 2022 - Wiley Online Library
COVID‐19 is a pandemic with high morbidity and mortality. In an autopsy cohort of COVID‐19
patients, we found extensive accumulation of the tryptophan degradation products 3‐…
patients, we found extensive accumulation of the tryptophan degradation products 3‐…
[HTML][HTML] Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
J de Brabander, E Duijvelaar… - European …, 2022 - Eur Respiratory Soc
Background Imatinib reduced 90-day mortality in hospitalised coronavirus disease 2019 (COVID-19)
patients in a recent clinical trial, but the biological effects that cause improved …
patients in a recent clinical trial, but the biological effects that cause improved …
[HTML][HTML] Age-related changes in plasma biomarkers and their association with mortality in COVID-19
…, B Appelman, J de Brabander… - European …, 2023 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19)-induced mortality occurs predominantly
in older patients. Several immunomodulating therapies seem less beneficial in these …
in older patients. Several immunomodulating therapies seem less beneficial in these …
[HTML][HTML] The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
…, D van de Beek, MK Bomers, J de Brabander… - …, 2023 - thelancet.com
Background Afucosylated IgG1 responses have only been found against membrane-embedded
epitopes, including anti-S in SARS-CoV-2 infections. These responses, intrinsically …
epitopes, including anti-S in SARS-CoV-2 infections. These responses, intrinsically …
[HTML][HTML] The platelet lipidome is altered in patients with COVID-19 and correlates with platelet reactivity
…, TDY Reijnders, J De Brabander… - Thrombosis and …, 2022 - thieme-connect.com
Background Activated platelets have been implicated in the proinflammatory and prothrombotic
phenotype of coronavirus disease 2019 (COVID-19). While it is increasingly recognized …
phenotype of coronavirus disease 2019 (COVID-19). While it is increasingly recognized …
[HTML][HTML] Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients
…, TDY Reijnders, A Saris, J de Brabander… - Thrombosis and …, 2021 - thieme-connect.com
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has rapidly spread worldwide since December 2019. Disease …
coronavirus-2 (SARS-CoV-2), has rapidly spread worldwide since December 2019. Disease …
